Isca Healthcare Research Limited

Financial Statements for the Period 30 November 2023 to 30 April 2025

DIRECTORS:

P Wall

R Wall

REGISTERED OFFICE:

Hill House

Belmont Hill

Caerleon

Newport

NP18 1JY

REGISTERED NUMBER:

08767654 (England and Wales)

ACCOUNTANTS:

BPU Limited

Chartered Accountants

Radnor House

Greenwood Close

Cardiff Gate Business Park

Cardiff

CF23 8AA

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Isca Healthcare Research Limited for the period ended 30 April 2025 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at icaew.com/membershandbook.

This report is made solely to the Board of Directors of Isca Healthcare Research Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Isca Healthcare Research Limited and state those matters that we have agreed to state to the Board of Directors of Isca Healthcare Research Limited, as a body, in this report in accordance with icaew/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Isca Healthcare Research Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Isca Healthcare Research Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Isca Healthcare Research Limited. You consider that Isca Healthcare Research Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of Isca Healthcare Research Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

BPU Limited

Chartered Accountants

10 December 2025

FIXED ASSETS

Intangible assets

3

-

Tangible assets

4

-

1,265

-

1,265

CURRENT ASSETS

Debtors

5

1,969

1,194

Cash at bank

7,103

9,133

9,072

10,327

CREDITORS

Amounts falling due within one year

6

12,784

11,109

NET CURRENT LIABILITIES

(3,712

)

(782

)

TOTAL ASSETS LESS CURRENT
LIABILITIES

(3,712

)

483

CAPITAL AND RESERVES

Called up share capital

10

Retained earnings

(3,722

)

473

SHAREHOLDERS' FUNDS

(3,712

)

483

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 April 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 November 2025 and were signed on its behalf by:

P Wall - Director

1.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover represents net invoiced sales of medical device consultancy services, excluding value added tax.

Goodwill

Goodwill is being amortised over its estimated useful life of 5 years, in accordance with FRS 10 - Accounting for Intangible Fixed Assets.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

33% reducing balance

2.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 (2023 - 2 ) .

3.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 30 November 2023

10,000

Disposals

(10,000

)

At 30 April 2025

-

AMORTISATION

At 30 November 2023

10,000

Eliminated on disposal

(10,000

)

At 30 April 2025

-

NET BOOK VALUE

At 30 April 2025

-

At 29 November 2023

-

4.	TANGIBLE FIXED ASSETS

Computer

equipment

£

COST

At 30 November 2023

7,219

Disposals

(7,219

)

At 30 April 2025

-

DEPRECIATION

At 30 November 2023

5,954

Charge for period

591

Eliminated on disposal

(6,545

)

At 30 April 2025

-

NET BOOK VALUE

At 30 April 2025

-

At 29 November 2023

1,265

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2023

£

Trade debtors

1,969

-

Other debtors & prepayments

-

1,194

1,969

1,194

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2023

£

Other creditors & accruals

12,784

11,109